June 26, 2025AstraZeneca's New Phase I Study on AZD5492: What Investors Need to Know ~1 min.AstraZeneca PLC has recently announced positive results from a Phase I study on its new drug candidate, AZD5492....
March 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires ~1 min.AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....
March 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster ~2 min.AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....
March 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market ~1 min.AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....
March 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment ~2 min.AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....
March 5, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 13.63% Profit ~1 min.On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....
March 4, 2025ASTRAZENECA PLC Hits Price Target Forecast with 13.62% Profit: A Sign of QuantWave's Accuracy ~2 min.ASTRAZENECA PLC (AZN) recently reached the price target forecast set by QuantWave on March 4, 2025, resulting in a profit of 13.62% for investors who followed the long signal issued on February 4, 2025....
February 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential ~2 min.AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....
February 26, 2025AstraZeneca PLC's Groundbreaking Research Leads to Exciting Discoveries in the Field of Medicine ~2 min.AstraZeneca PLC, a leading pharmaceutical company, has made significant advancements in the field of medicine through its groundbreaking research....
February 24, 2025AstraZeneca PLC Announces Positive Results from Clinical Trial ~2 min.AstraZeneca PLC, a leading pharmaceutical company, announced today that its latest clinical trial for a new drug has yielded positive results....
April 25, 2024ASTRAZENECA PLC Hits Price Target Forecast with 18.52% Profit ~1 min.ASTRAZENECA PLC, a leading pharmaceutical company, recently reached the price target forecast set by QuantWave with an impressive profit margin of 18.52%....
January 1, 2025Stocks Prognosis: Is AstraZeneca PLC AZN Set to Become a U.K. Dividend Champion by 2024? ~2 min.AstraZeneca PLC, a leading global pharmaceutical company, is garnering attention from investors as it seeks to establish itself as a U.K. Dividend Champion by 2024....
May 21, 2024ASTRAZENECA PLC Stock Hits Price Target Forecast with 16.67% Profit – QuantWave Analysis ~1 min.ASTRAZENECA PLC (NYSE: AZN) stock successfully reached its price target forecast as predicted by QuantWave's automated forecasting platform....
November 15, 2024AstraZeneca PLC: Strong Growth Potential And Market Volatility Offer Opportunity ~2 min.AstraZeneca PLC (AZN) is a leading pharmaceutical company that has recently shown strong growth potential amidst market volatility....
May 1, 2024ASTRAZENECA PLC Hits Price Target Forecast with 15.33% Profit, Showcasing the Accuracy of QuantWave's Analytics ~2 min.ASTRAZENECA PLC has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 15.33%. The forecast signal was given on January 16, 2024, with the stock priced at 64.92 $....
